AFP and central nervous system neoplasm: High clinical suspicion, determination of serum markers (AFP and β-hCG) and histologic confirmation should guide the management of patients with mediastinal, retroperitoneal, and midline CNS tumors, in the setting of multidisciplinary tumor boards, to identify a subset of highly curable patients [6].